Dogs & Cats

Doxycycline for Tick-Borne Disease in Dogs and Cats: Ehrlichia, Anaplasma, RMSF, and Lyme

Jul 2, 2026 6 min read
Updated Nov 3, 2026AI-generated clinical reference · Sources and methodology

Bottom line

  • Doxycycline is the treatment of choice for the principal tick-borne bacterial infections in companion animals, including canine monocytic ehrlichiosis (Ehrlichia canis), canine and feline anaplasmosis (Anaplasma phagocytophilum, A. platys), Rocky Mountain spotted fever (Rickettsia rickettsii), and Lyme disease (Borrelia burgdorferi).
  • For canine ehrlichiosis, the professional reference specifies doxycycline 5 mg/kg PO or IV every 12 hours, or 10 mg/kg PO or IV every 24 hours, for 28 days. [4] For canine Lyme disease, CAPC recommends 10 mg/kg orally every 24 hours for 30 days. [3]
  • Early clinical improvement does not establish pathogen clearance. Complete the pathogen-specific course; the Fourie experiment documented recurrent E. canis PCR positivity after its initial shorter course. [1]
  • The generic DoxyVet formulation showed efficacy in a six-dog experimental E. canis infection study; there was no branded comparator arm, so that study does not establish equivalence to brand formulations. [1]
  • Administer with food to reduce esophageal irritation; follow each dose with water or food and avoid dosing immediately before lying down.
  • This is a clinician-facing evidence summary. It is not a treatment protocol; confirm drug dosing against current formularies and current CAPC/ACVIM guidelines.

From reading to clinical reasoning

Pressure-test the decisions behind this article

Open Clinical Desk with the public topic prefilled. Add patient context only after you are inside the secure vet workspace.

doxycycline tick borne disease dogs cats

Patient details stay inside the authenticated workspace.

Clinical facts

  • Drug class: Tetracycline antibiotic; bacteriostatic; inhibits 30S ribosomal subunit, blocking protein synthesis of obligate intracellular organisms.
  • Target pathogens: Ehrlichia canis (canine monocytic ehrlichiosis, CME), Ehrlichia ewingii (canine granulocytic ehrlichiosis), Anaplasma phagocytophilum (granulocytic anaplasmosis, dogs and cats), Anaplasma platys (canine cyclic thrombocytopenia), Rickettsia rickettsii (RMSF), Borrelia burgdorferi (Lyme disease, dogs), Neorickettsia spp., and Bartonella spp. (partial response).
  • Canine ehrlichiosis regimen: doxycycline 5 mg/kg PO or IV every 12 hours, or 10 mg/kg PO or IV every 24 hours, for 28 days. [4] For canine Lyme disease, 10 mg/kg orally every 24 hours for 30 days. [3] Do not extend that canine ehrlichiosis regimen to every pathogen or to cats; consult indication- and species-specific guidance.
  • Esophageal safety: Doxycycline is irritating to the esophageal mucosa; esophageal stricture is a well-documented complication in cats following dry tablet administration. Always administer with food and follow with water or food in cats; liquid suspension or doxycycline hyclate capsules dissolved in water are preferred in cats.
  • Monitoring: Serum chemistry and CBC at baseline and at recheck (typically day 28 post-treatment) in dogs with thrombocytopenia or hypoalbuminemia at presentation. PCR of peripheral blood can be used to confirm clearance in persistently seropositive or clinically unresolved cases.
  • Resistance: Persistent illness or PCR positivity warrants reassessment of diagnosis, adherence, reinfection and coinfections; it does not by itself establish antimicrobial resistance.

What the evidence shows

Generic doxycycline efficacy in canine monocytic ehrlichiosis

Fourie et al. (2015) evaluated DoxyVet in six dogs experimentally infected with E. canis through infected ticks. The first course targeted 10 mg/kg PO once daily for 20 consecutive days; the actual administered dose ranged from 10 to 11.7 mg/kg. PCR detected no E. canis DNA in any dog on study day 28. Four dogs became PCR-positive again on day 56 and a fifth on day 70; the sixth remained clinically normal and left the study on day 84. The five dogs with recurrent infection received a further 28-day course. Four had no positive PCR results during the following three months; the fifth became positive again 58 days after the last dose of that second course and received rescue treatment. These findings support the need for adequate treatment duration and follow-up, but neither establish universal eradication nor compare generic with branded formulations. [1]

CAPC guidelines: Ehrlichia and Anaplasma treatment recommendations

CAPC recommends a 28-day doxycycline course for Ehrlichia/Anaplasma infections. [2] The full route/frequency regimen above comes from the separate professional canine ehrlichiosis reference, not from the CAPC page. [4] Do not transfer that duration to every tick-borne pathogen or infer clearance solely from early clinical improvement. The separate canine Lyme guideline recommends 30 days. [3]

Practical species-specific considerations

Dogs: The acute presentation of E. canis CME (fever, lethargy, lymphadenopathy, thrombocytopenia, epistaxis) responds rapidly to doxycycline; complete blood count recovery typically lags clinical improvement. Chronic CME with pancytopenia and bone marrow hypoplasia carries a guarded prognosis even with appropriate therapy. Suspected RMSF requires prompt clinical assessment and indication-specific treatment; this hub does not provide a separate RMSF dose or quantified treatment-delay prognosis.

Cats: Doxycycline is used for A. phagocytophilum in cats, though feline anaplasmosis is less commonly diagnosed and typically mild. Esophageal stricture risk in cats is a genuine clinical concern with tablet administration; using a compounded liquid or gel-cap formulation with food, followed by a water flush, is strongly preferred. Do not infer a feline regimen from a canine guideline; confirm the suspected pathogen and feline-specific regimen before prescribing.

How this fits clinical practice

Use a pathogen- and species-specific regimen rather than treating every positive tick-borne screen identically. CAPC recommends 28 days for canine Ehrlichia/Anaplasma infections. [2] Its canine Lyme recommendation is 30 days. [3] The experimental E. canis recurrence findings support follow-up rather than assuming a negative early PCR proves eradication. [1] Reassess diagnosis, administration, reinfection and coinfections when illness persists; seropositivity alone does not identify the cause of every clinical sign.

Always confirm drug dosing, species-specific formulation guidance, and tick-borne disease testing protocols against current CAPC guidelines and formulary.

Frequently Asked Questions

What is the standard doxycycline dose for tick-borne disease in dogs and cats?

For canine ehrlichiosis, the professional reference specifies doxycycline 5 mg/kg PO or IV every 12 hours, or 10 mg/kg PO or IV every 24 hours, for 28 days. [4] For canine Lyme disease, CAPC recommends 10 mg/kg orally every 24 hours for 30 days. [3] Other pathogens and cats require their own indication- and species-specific guidance; do not extrapolate the canine ehrlichiosis regimen.

Which tick-borne pathogens does doxycycline treat in companion animals?

Doxycycline is the treatment of choice for canine monocytic ehrlichiosis (Ehrlichia canis), canine granulocytic ehrlichiosis (E. ewingii), granulocytic anaplasmosis (Anaplasma phagocytophilum in dogs and cats), canine cyclic thrombocytopenia (A. platys), Rocky Mountain spotted fever (Rickettsia rickettsii), and Lyme disease (Borrelia burgdorferi). It also covers Neorickettsia spp. and gives a partial response against Bartonella spp.

Why should early improvement not shorten the prescribed Ehrlichia/Anaplasma course?

CAPC recommends 28 days for canine Ehrlichia/Anaplasma infections. [2] Clinical improvement alone does not prove eradication: recurrent E. canis PCR positivity followed the initial shorter course in the Fourie experiment. [1] Duration must still be selected for the actual pathogen; the separate canine Lyme guideline recommends 30 days. [3]

Is generic doxycycline as effective as brand formulations for Ehrlichia canis?

The cited Fourie experiment does not establish generic-versus-brand equivalence because it had no branded comparator. Six dogs with experimental tick-transmitted E. canis infection initially became PCR-negative, but five later had recurrent PCR positivity and required retreatment. The study documents results for DoxyVet, not a comparative equivalence conclusion. [1]

How should doxycycline be administered to cats to prevent esophageal stricture?

Doxycycline is irritating to the esophageal mucosa and esophageal stricture is a well-documented complication in cats after dry tablet administration. Always give it with food and follow each dose with water or food; liquid suspension or hyclate capsules dissolved in water are preferred in cats, and dosing immediately before lying down should be avoided.

What monitoring is recommended during doxycycline treatment for tick-borne disease?

Serum chemistry and CBC should be checked at baseline and at recheck (typically day 28 post-treatment) in dogs with thrombocytopenia or hypoalbuminemia at presentation. PCR of peripheral blood can confirm clearance in persistently seropositive or clinically unresolved cases.

Is doxycycline resistance a concern in tick-borne Ehrlichia infections?

Persistent illness or PCR positivity does not by itself establish resistance. Reassess diagnosis, adherence, reinfection and coinfections rather than assuming that every recurrence is a resistant infection.

Why is Rocky Mountain spotted fever (RMSF) treated as an emergency with doxycycline?

Suspected RMSF warrants prompt clinical assessment and pathogen-specific treatment. This article does not establish a separate RMSF dosing schedule or a quantified treatment-delay mortality threshold; consult dedicated current guidance.

Changelog

  • 2026-07-02: First published.

References

  1. Fourie JJ, Horak I, Crafford D, Erasmus HL, Botha OJ. The efficacy of a generic doxycycline tablet in the treatment of canine monocytic ehrlichiosis. J S Afr Vet Assoc. 2015;86(1):1193. DOI: 10.4102/jsava.v86i1.1193. PMID: 26018824. (2015)
  2. Companion Animal Parasite Council (CAPC). Ehrlichia spp. and Anaplasma spp. Treatment Guidelines. (2015)
  3. Companion Animal Parasite Council — Lyme Disease: canine treatment guidance (accessed November 2026) (2026)
  4. MSD Veterinary Manual (professional) — Ehrlichiosis in Dogs: treatment (accessed November 2026) (2026)

More clinical updates